MOORESTOWN, N.J., Aug. 17, 2021 /PRNewswire/ -- Tabula Rasa
HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading
healthcare technology company advancing the safe use of
medications, announced several new agreements to bolster
traditional Medication Therapy Management (MTM) programs with
TRHC's MedWise® technology. TRHC's EMTM helps healthcare providers
and insurers to better predict which patients are at risk for
multi-drug interactions, reducing adverse drug events (ADEs),
lowering costs and improving patient outcomes.
Through these agreements the combined MTM / EMTM program will be
used to enhance a national Medication MTM program and a regional
Blue's traditional Medicare MTM program.
Medication problems resulting from dangerous drug interactions
are a major cause of hospitalization and death in the U.S. TRHC's
proprietary MedWise® technology assesses the combined risk of a
patient's medications, incorporating pharmacogenomics,
pharmacokinetics, and pharmacodynamics to identify the potential
for multi-drug interactions.
Applying TRHC's propriety MedWise technology to traditional MTM
programs will permit providers and insurers to more accurately
target patients who may be at high risk for ADEs, reducing costs
and improving patient care. These patients can then receive
Medication Safety Reviews™, which will further illuminate
multi-drug interactions and offer interventions to enhance
medication safety.
"Research has clearly demonstrated the ability of our MedWise
technology to identify individuals at higher risk of ADEs," said
TRHC Chairman and CEO Calvin H.
Knowlton, PhD. "By targeting these patients for
comprehensive medication reviews, we can help physicians make safer
prescribing choices, fostering better outcomes."
Peer-reviewed, published studies have found that a lower MedWise
Risk Score™, correlated with fewer ADEs, emergency department
visits, and hospitalizations; lower medical costs; and a decreased
risk of premature death.
To learn more about TRHC and its offerings, visit us online
here.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication
safety solutions that empower healthcare professionals and
consumers to optimize medication regimens, combatting medication
overload and reducing adverse drug events – the fourth leading
cause of death in the US. TRHC's proprietary technology solutions,
including MedWise®, improve patient outcomes, reduce
hospitalizations, and lower healthcare costs. TRHC's extensive
clinical tele-pharmacy network improves care for patients
nationwide. Its solutions are trusted by health plans and
pharmacies to help drive value-based care. For more information,
visit TRHC.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tabula-rasa-healthcare-expands-medwise-technology-offerings-to-key-markets-301357099.html
SOURCE Tabula Rasa HealthCare, Inc.